info@ucallmlabs.com
ChIP (Chromatin Immunoprecipitation)
1.1 Introduction
Chromatin Immunoprecipitation (ChIP) is a classical epigenetic technique for studying in vivo protein‑DNA interactions, serving as a core tool for deciphering gene expression regulatory mechanisms, transcription factor binding sites, and epigenetic modification landscapes. By using specific antibodies to enrich DNA fragments bound to target proteins (such as transcription factors and histone modifications), ChIP provides an authentic reflection of in vivo protein‑DNA binding. It is considered the gold standard for studying gene regulation, epigenetics, and chromatin structure. The core principle of ChIP is to “freeze” protein‑DNA interactions in living cells via formaldehyde crosslinking, fragment chromatin into 200‑1000 bp pieces, capture target protein‑DNA complexes through specific antibody immunoprecipitation, reverse crosslinks to release and purify the DNA, and finally detect and analyze the enriched DNA fragments using qPCR, ChIP‑seq, or ChIP‑chip, thereby authentically reflecting in vivo protein‑genome binding events.
1.2 Products
1.3 Applications
| Application | Description |
|---|---|
| Transcription factor binding site mapping | Genome‑wide identification of cis‑regulatory elements (promoters, enhancers, silencers) where transcription factors bind, revealing gene regulatory networks. |
| Histone modification profiling and epigenomic mapping | Systematic cataloging of histone marks to define chromatin states, active/inactive domains, and cell identity. |
| Nucleosome positioning and chromatin architecture | Mapping nucleosome occupancy, positioning, and remodeling dynamics to understand DNA accessibility, replication, and repair mechanisms. |
| Differential binding and dynamic gene regulation | Comparative ChIP‑seq across cell types, developmental stages, or disease states to identify condition‑specific regulatory changes and bivalent domains. |
| Disease mechanism and therapeutic target discovery | Identifying aberrant TF binding, epigenetic alterations, and chromatin remodeling in cancer and other diseases; guiding drug target screening. |
1.4 References:
- Johnson DS, Mortazavi A, Myers RM, Wold B. Genome‑wide mapping of in vivo protein‑DNA interactions. Science. 2007 Jun 8;316(5830):1497‑502. doi: 10.1126/science.1141319. Epub 2007 May 31. PMID: 17540862.
- Park PJ. ChIP‑seq: advantages and challenges of a maturing technology. Nat Rev Genet. 2009 Oct;10(10):669‑80. doi: 10.1038/nrg2641. Epub 2009 Sep 8. PMID: 19736561; PMCID: PMC3191340.
- Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, Wei G, Chepelev I, Zhao K. High‑resolution profiling of histone methylations in the human genome. Cell. 2007 May 18;129(4):823‑37. doi: 10.1016/j.cell.2007.05.009. PMID: 17512414.
- Mikkelsen TS, Ku M, Jaffe DB, Issac B, Lieberman E, Giannoukos G, Alvarez P, Brockman W, Kim TK, Koche RP, Lee W, Mendenhall E, O'Donovan A, Presser A, Russ C, Xie X, Meissner A, Wernig M, Jaenisch R, Nusbaum C, Lander ES, Bernstein BE. Genome‑wide maps of chromatin state in pluripotent and lineage‑committed cells. Nature. 2007 Aug 2;448(7153):553‑60. doi: 10.1038/nature06008. Epub 2007 Jul 1. PMID: 17603471; PMCID: PMC2921165.
- Farnham PJ. Insights from genomic profiling of transcription factors. Nat Rev Genet. 2009 Sep;10(9):605‑16. doi: 10.1038/nrg2636. Epub 2009 Aug 11. PMID: 19668247; PMCID: PMC2846386.
- Visel A, Blow MJ, Li Z, Zhang T, Akiyama JA, Holt A, Plajzer‑Frick I, Shoukry M, Wright C, Chen F, Afzal V, Ren B, Rubin EM, Pennacchio LA. ChIP‑seq accurately predicts tissue‑specific activity of enhancers. Nature. 2009 Feb 12;457(7231):854‑8. doi: 10.1038/nature07730. PMID: 19212405; PMCID: PMC2745234.